Ardent Health Partners’ (ARDT) Overweight Rating Reaffirmed at Stephens

Stephens reaffirmed their overweight rating on shares of Ardent Health Partners (NYSE:ARDT) in a research report report published on Tuesday,Benzinga reports. The brokerage currently has a $22.00 price objective on the stock.

A number of other research analysts have also recently issued reports on the stock. Morgan Stanley cut their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday, January 21st. Royal Bank of Canada cut their price objective on Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a research report on Tuesday, March 4th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Finally, Truist Financial lowered their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $21.18.

Ardent Health Partners Price Performance

Shares of NYSE:ARDT opened at $12.92 on Tuesday. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The business’s fifty day moving average price is $14.38 and its two-hundred day moving average price is $16.15. Ardent Health Partners has a fifty-two week low of $12.39 and a fifty-two week high of $20.72.

Ardent Health Partners (NYSE:ARDT) last posted its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.48 billion. Sell-side analysts anticipate that Ardent Health Partners will post 1.23 earnings per share for the current year.

Institutional Trading of Ardent Health Partners

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Ardent Health Partners during the 4th quarter worth approximately $27,000. US Bancorp DE bought a new position in Ardent Health Partners in the fourth quarter valued at approximately $31,000. R Squared Ltd acquired a new stake in Ardent Health Partners during the 4th quarter worth $37,000. BNP Paribas Financial Markets bought a new stake in shares of Ardent Health Partners during the 3rd quarter valued at $42,000. Finally, New York State Common Retirement Fund acquired a new position in shares of Ardent Health Partners in the 4th quarter valued at $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.